NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution.
NMR
X-ray
hCC V57G variant
human cystatin C
protein structure
Journal
The FEBS journal
ISSN: 1742-4658
Titre abrégé: FEBS J
Pays: England
ID NLM: 101229646
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
15
05
2019
revised:
14
06
2019
accepted:
19
07
2019
pubmed:
23
7
2019
medline:
21
10
2020
entrez:
23
7
2019
Statut:
ppublish
Résumé
Human cystatin C (hCC), a member of the superfamily of papain-like cysteine protease inhibitors, is the most widespread cystatin in human body fluids. This small protein, in addition to its physiological function, is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, stroke, and dementia. Physiologically active hCC is a monomer. However, all structural studies based on crystallization led to the dimeric structure formed as a result of a three-dimensional exchange of the protein domains (3D domain swapping). The monomeric structure was obtained only for hCC variant V57N and for the protein stabilized by an additional disulfide bridge. With this study, we extend the number of models of monomeric hCC by an additional hCC variant with a single amino acid substitution in the flexible loop L1. The V57G variant was chosen for the X-ray and NMR structural analysis due to its exceptional conformational stability in solution. In this work, we show for the first time the structural and dynamics studies of human cystatin C variant in solution. We were also able to compare these data with the crystal structure of the hCC V57G and with other cystatins. The overall cystatin fold is retained in the solute form. Additionally, structural information concerning the N terminus was obtained during our studies and presented for the first time. DATABASE: Crystallographic structure: structural data are available in PDB databases under the accession number 6ROA. NMR structure: structural data are available in PDB and BMRB databases under the accession numbers 6RPV and 34399, respectively.
Substances chimiques
CST3 protein, human
0
Cystatin C
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
361-376Informations de copyright
© 2019 Federation of European Biochemical Societies.
Références
Levy E, Jaskolski M & Grubb A (2006) The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models. Brain Pathol 16, 60-70.
Grubb AO (2000) Cystatin C - properties and use as diagnostic marker. Adv Clin Chem 35, 63-99.
Olafsson I, Grubb A, Olafson I & Grubb A (2000) Hereditary cystatin C amyloid angiopathy. Amyloid 7, 70-79.
Jensson O, Gudmundsson G, Arnason A, Blöndal H, Petursdottir I, Thorsteinsson L, Grubb A, Löfberg H, Cohen D & Frangione B (1987) Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. Acta Neurol Scand 76, 102-114.
Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A & Jensson O (1989) Mutation in the cystatin C gene causes hereditary brain hemorrhage. Prog Clin Biol Res 317, 241-246.
Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI & Wisniewski HM (1997) Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 173, 423-432.
Ekiel I & Abrahamson M (1996) Folding-related dimerization of human cystatin C. J Biol Chem 271, 1314-1321.
Wahlbom M, Wang X, Lindström V, Carlemalm E, Jaskolski M & Grubb A (2007) Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J Biol Chem 282, 18318-18326.
Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M & Jaskolski M (2001) Human cystatin C, an amyloidogenic protein, dimerizes through three- dimensional domain swapping. Nat Struct Biol 8, 316-320.
Östner G, Lindström V, Hjort Christensen P, Kozak M, Abrahamson M & Grubb A (2013) Stabilization, characterization, and selective removal of cystatin C amyloid oligomers. J Biol Chem 288, 16438-16450.
Rodziewicz-Motowidło S, Wahlbom M, Wang X, Lagiewka J, Janowski R, Jaskólski M, Grubb A & Grzonka Z (2006) Checking the conformational stability of cystatin C and its L68Q variant by molecular dynamics studies: Why is the L68Q variant amyloidogenic? J Struct Biol 154, 68-78.
Rodziewicz-Motowidło S, Iwaszkiewicz J, Sosnowska R, Czaplewska P, Sobolewski E, Szymańska A, Stachowiak K & Liwo A (2009) The role of the Val57 amino-acid residue in the hinge loop of the human cystatin C. Conformational studies of the beta2-L1-beta3 segments of wild-type human cystatin C and its mutants. Biopolymers 91, 373-383.
Szymańska A, Jankowska E, Orlikowska M, Behrendt I, Czaplewska P & Rodziewicz-Motowidło S (2012) Influence of point mutations on the stability, dimerization, and oligomerization of human cystatin C and its L68Q variant. Front Mol Neurosci 5, 82.
Szymańska A, Radulska A, Czaplewska P, Grubb A, Grzonka Z & Rodziewicz-Motowidło S (2009) Governing the monomer-dimer ratio of human cystatin C by single amino acid substitution in the hinge region. Acta Biochim Pol 56, 455-463.
Orlikowska M, Jankowska E, Kołodziejczyk R, Jaskólski M & Szymańska A (2011) Hinge-loop mutation can be used to control 3D domain swapping and amyloidogenesis of human cystatin C. J Struct Biol 173, 406-413.
Orlikowska E, Jankowska E, Borek D, Kolodziejczyk R, Otwinowski Z, Jaskolski M & Szymanska A (2010) Effect of point mutation in the hinge region on a structure of an amyloidogenic protein - human cystatin C. J Pept Sci 16, 110-111.
Bennett MJ, Sawaya MR & Eisenberg D (2006) Deposition diseases and 3D domain swapping. Structure 14, 811-824.
Zerovnik E, Stoka V, Mirtic A, Guncar G, Grdadolnik J, Staniforth RA, Turk D & Turk V (2011) Mechanisms of amyloid fibril formation - focus on domain-swapping. FEBS J 278, 2263-2282.
van der Wel PCA (2012) Domain swapping and amyloid fibril conformation. Prion 6, 211-216.
Ekiel I, Abrahamson M, Fulton DB, Lindahl P, Storer AC, Levadoux W, Lafrance M, Labelle S, Pomerleau Y, Groleau D et al. (1997) NMR structural studies of human cystatin C dimers and monomers. J Mol Biol 271, 266-277.
Tate S, Ushioda T, Utsunomiya-Tate N, Shibuya K, Ohyama Y, Nakano Y, Kaji H, Inagaki F, Samejima T & Kainosho M (1995) Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A. Biochemistry 34, 14637-14648.
Shimba N, Kariya E, Tate S, Kaji H & Kainosho M (2000) Structural comparison between wild-type and P25S human cystatin A by NMR spectroscopy. Does this mutation affect the α-helix conformation? J Struct Funct Genomics 1, 26-42.
Dieckmann T, Mitschang L, Hofmann M, Kos J, Turk V, Auerswald EA, Jaenicke R & Oschkinat H (1993) The structures of native phosphorylated chicken cystatin and of a recombinant unphosphorylated variant in solution. J Mol Biol 234, 1048-1059.
Irene D, Chen B-J, Lo S-H, Liu T-H, Tzen JT-C & Chyan C-L (2012) Resonance assignments and secondary structure of a phytocystatin from Ananas comosus. Biomol NMR Assign 6, 99-101.
Japelj B, Waltho JP & Jerala R (2004) Comparison of backbone dynamics of monomeric and domain-swapped stefin A. Proteins Struct Funct Bioinforma 54, 500-512.
Janowski R, Abrahamson M, Grubb A & Jaskolski M (2004) Domain swapping in N-truncated human cystatin C. J Mol Biol 341, 151-160.
Janowski R, Kozak M, Abrahamson M, Grubb A & Jaskolski M (2005) 3D domain-swapped human cystatin C with amyloidlike intermolecular beta-sheets. Proteins 61, 570-578.
Kolodziejczyk R, Michalska K, Hernandez-Santoyo A, Wahlbom M, Grubb A & Jaskolski M (2010) Crystal structure of human cystatin C stabilized against amyloid formation. FEBS J 277, 1726-1737.
Nilsson M, Wang X, Rodziewicz-Motowidlo S, Janowski R, Lindström V, Onnerfjord P, Westermark G, Grzonka Z, Jaskolski M & Grubb A (2004) Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. J Biol Chem 279, 24236-24245.
Orlikowska M, Szymańska A, Borek D, Otwinowski Z, Skowron P & Jankowska E (2013) Structural characterization of V57D and V57P mutants of human cystatin C, an amyloidogenic protein. Acta Crystallogr D Biol Crystallogr 69, 577-586.
Orlikowska M, Jankowska E, Borek D, Otwinowski Z, Skowron P & Szymańska A (2011) Crystallization and preliminary X-ray diffraction analysis of Val57 mutants of the amyloidogenic protein human cystatin C. Acta Crystallogr Sect F Struct Biol Cryst Commun 67, 1608-1611.
Opitz C, Ahrné E, Goldie KN, Schmidt A & Grzesiek S (2019) Deuterium induces a distinctive Escherichia coli proteome that correlates with the reduction in growth rate. J Biol Chem 294, 2279-2292.
Maszota-Zieleniak M (2017) Struktura i dynamika peptydów i białek amyloidogennych na przykładzie serum amyloidu A i ludzkiej cystatyny C. Ph.D. Thesis, Faculty of Chemistry, University of Gdańsk.
Behrendt I (2010) Badanie wpływu mutacji Val57-Gly na stabilność konformacyjną monomeru ludzkiej cystatyny C. M.Sc Thesis, Faculty of Chemistry, University of Gdańsk.
Turk V, Stoka V & Turk D (2008) Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 13, 5406-5420.
Otwinowski Z & Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307-326.
Vagin A & Teplyakov A (1997) MOLREP: an Automated Program for Molecular Replacement. J Appl Crystallogr 30, 1022-1025.
Murshudov GN, Skubák P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F & Vagin AA (2011) REFMAC 5 for the refinement of macromolecular crystal structures. Acta Crystallogr Sect D Biol Crystallogr 67, 355-367.
Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AGW, McCoy A et al. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr Sect D 67, 235-242.
Engh RA, Dieckmann T, Bode W, Auerswald EA, Turk V, Huber R & Oschkinat H (1993) Conformational Variability of Chicken Cystatin: Comparison of Structures Determined by X-ray Diffraction and NMR Spectroscopy. J Mol Biol 234, 1060-1069.
Staniforth RA, Giannini S, Higgins LD, Conroy MJ, Hounslow AM, Jerala R, Craven CJ & Waltho JP (2001) Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J 20, 4774-4781.
Abrahamson M, Ritonja A, Brown MA, Grubb A, Machleidt W & Barrett AJ (1987) Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem 262, 9688-9694.
Abrahamson M, Mason RW, Hansson H, Buttle DJ, Grubb A & Ohlsson K (1991) Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J 273 (Pt 3), 621-626.
Stubbs MT, Laber B, Bode W, Huber R, Jerala R, Lenarcic B & Turk V (1990) The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J 9, 1939-1947.
Bracken C, Marley J & Lu M (2001) A method for efficient isotopic labeling of recombinant proteins. J Biomol NMR 20, 71-75.
Neu HC & Heppel LA (1965) The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J Biol Chem 240, 3685-3692.
Sattler M, Schleucher J & Griesinger C (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution. Prog Nucl Magn Reson Spectrosc 34, 93-158.
Wishart D, Bigam C, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley J & Sykes B (1995) 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6, 135-140.
Delaglio F, Grzesiek S, Vuister G, Zhu G, Pfeifer J & Bax A (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 277-293.
Lee W, Tonelli M & Markley JL (2015) NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 31, 1325.
Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, Gish G, Shoelson SE, Pawson T, Forman-Kay JD & Kay LE (1994) Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 33, 5984-6003.
Press WH, Teukolsky SA, Vetterlink WT & Flannery BP (2007) Numerical Recipes: The Art of Scientific Computing, 3rd edn. Cambridge University Press, Cambridge, UK.
Fushman D (2008) Determination of Protein Dynamics Using 15 N Relaxation Measurements. Protein Science Encyclopedia, pp. 283-308. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany.
Goddard TD & Kneller DG (2004) SPARKY 3. Univ. California, San Fr. 14, 15.
Shen Y, Bryan PN, He Y, Orban J, Baker D & Bax A (2010) De novo structure generation using chemical shifts for proteins with high-sequence identity but different folds. Protein Sci 19, 349-356.
Güntert P, Mumenthaler C & Wüthrich K (1997) Torsion angle dynamics for NMR structure calculation with the new program Dyana. J Mol Biol 273, 283-298.
Shen Y & Bax A (2013) Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J Biomol NMR 56, 227-241.
Schwieters CD, Kuszewski JJ, Tjandra N & Clore GM (2003) The Xplor-NIH NMR molecular structure determination package. J Magn Reson 160, 65-73.
Krieger E, Koraimann G & Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field. Proteins 47, 393-402.
Vriend G (1990) WHAT IF: a molecular modeling and drug design program. J Mol Graph 8, 52-56 29.
Taube M, Piertalik Z, Szymańska A, Szutkoski K, Clemens D, Grubb A & Kozak M (2019) The domain swapping of human cystatin C induced by synchrotron radiation. Sci Rep 9, 8548.
Minor W, Cymborowski M, Otwinowski Z & Chruszcz M (2006) HKL-3000: the integration of data reduction and structure solution-from diffraction images to an initial model in minutes. Acta Crystallogr D Biol Crystallogr 62, 859-866.
Emsley P & Cowtan K (2004) Coot : model-building tools for molecular graphics. Acta Crystallogr Sect D Biol Crystallogr 60, 2126-2132.
Painter J & Merritt EA (2005) A molecular viewer for the analysis of TLS rigid-body motion in macromolecules. Acta Crystallogr Sect D 61, 465-471.
Brünger AT (1992) Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475.
Laskowski RA, MacArthur MW, Moss DS & Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26, 283-291.
Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS & Richardson DC (2010) MolProbity : all-atom structure validation for macromolecular crystallography. Acta Crystallogr Sect D Biol Crystallogr 66, 12-21.
The PyMOL Molecular Graphic System, Version 2.0, Schrödinger LCC.
Koradi R, Billeter M & Wüthrich K (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14, 29-32-55.